Vergenix™FG IS A RECOMBINANT HUMAN COLLAGEN
MATRIX FOR THE MANAGEMENT OF CHRONIC AND ACUTE WOUNDS
Produced via bioengineered
Identical to type I collagen
produced by the human body
3D scaffold for deep/
irregular wound shapes
A single application
“Vegrenix™FG is the most effective filler I used so far.
It is easy to use, and in my surgical practice helps me
in addressing problems with loss of substance after
debridement or bone and joint removal for osteomyelitis.
In two words: IT WORKS”
Prof. Alberto Piaggesi
Director, Diabetic Foot Section, University of Pisa,
Member of Board of Directors of Diabetic Foot Study
Group of European Association. Honorary Secretary – EWMA
NEWS & EVENTS
Clinical study publication
Study published in Wounds Journal shows remarkable wound closure performance with Vergenix™FG in the treatment of chronic wounds.
Dr. Eyal Shapira wins the first time international presenter prize at the EWMA 2019 with an oral presentation about Vergenix™FG.